Research Reports

Key takeaways

Medirom must repay principal and interest under the Original Agreement by April 30, 2026.

Medirom to promptly pay Kufu interest accrued through March 31, 2026 after executing the Memorandum.

Early repayment by April 30, 2026 triggers Kufu's deemed consent under the Original Agreement.

Interest accrues only through April 30, 2026 if repaid by that date.

Original Agreement remains in full force except where this Memorandum conflicts.

Memorandum executed on March 31, 2026 by CEOs Yoshiteru Akita and Kouji Eguchi.

Full analysis

This Memorandum modifies the repayment terms of an existing Deemed Loan Agreement between Medirom and Kufu, originally dated January 30, 2026. The extension to April 30, 2026 provides Medirom additional time to settle the obligation, reducing immediate liquidity pressure while requiring immediate payment of accrued interest through March 31, 2026. Investors should note the preservation of the Original Agreement's terms, ensuring continuity of prior conditions, with this document prevailing in conflicts. The agreement was executed on March 31, 2026, signaling a negotiated resolution to potential default risks.

MRM · MEDIROM Healthcare Technologies Inc.

Summary

Key takeaways

Full analysis